BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 15449861)

  • 1. Building deals on bedrock.
    Harding D; Rovit S
    Harv Bus Rev; 2004 Sep; 82(9):121-8, 138. PubMed ID: 15449861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Not all M&As are alike--and that matters.
    Bower JL
    Harv Bus Rev; 2001 Mar; 79(3):92-101, 164. PubMed ID: 11246927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How industries change.
    McGahan AM
    Harv Bus Rev; 2004 Oct; 82(10):86-94, 156. PubMed ID: 15559578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The five competitive forces that shape strategy.
    Porter ME
    Harv Bus Rev; 2008 Jan; 86(1):78-93, 137. PubMed ID: 18271320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. M&A needn't be a loser's game.
    Selden L; Colvin G
    Harv Bus Rev; 2003 Jun; 81(6):70-9, 137. PubMed ID: 12800718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Master of the house: Why a company should take control of its building projects.
    Thurm D
    Harv Bus Rev; 2005 Oct; 83(10):120-9, 158. PubMed ID: 16250630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capitalizing on capabilities.
    Ulrich D; Smallwood N
    Harv Bus Rev; 2004 Jun; 82(6):119-27, 138. PubMed ID: 15202293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing for value. It's not just about the numbers.
    Haspeslagh P; Noda T; Boulos F
    Harv Bus Rev; 2001; 79(7):64-73, 144. PubMed ID: 11447618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategic sourcing: from periphery to the core.
    Gottfredson M; Puryear R; Phillips S
    Harv Bus Rev; 2005 Feb; 83(2):132-9, 150. PubMed ID: 15724581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deep change. How operational innovation can transform your company.
    Hammer M
    Harv Bus Rev; 2004 Apr; 82(4):84-93, 141. PubMed ID: 15077369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. When to ally & when to acquire.
    Dyer JH; Kale P; Singh H
    Harv Bus Rev; 2004; 82(7-8):108-15, 188. PubMed ID: 15241957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. When to walk away from a deal.
    Cullinan G; Le Roux JM; Weddigen RM
    Harv Bus Rev; 2004 Apr; 82(4):96-104, 141. PubMed ID: 15077370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Take command of your growth.
    Treacy M; Sims J
    Harv Bus Rev; 2004 Apr; 82(4):127-33, 142. PubMed ID: 15077373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mastering the value chain. An interview with Mark Levin of Millennium Pharmaceuticals. Interview by David Champion.
    Levin M
    Harv Bus Rev; 2001 Jun; 79(6):108-15, 148. PubMed ID: 11408971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Turning negotiation into a corporate capability.
    Ertel D
    Harv Bus Rev; 1999; 77(3):55-60, 62-70, 213. PubMed ID: 10387578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why business models matter.
    Magretta J
    Harv Bus Rev; 2002 May; 80(5):86-92, 133. PubMed ID: 12024761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Divestiture: strategy's missing link.
    Dranikoff L; Koller T; Schneider A
    Harv Bus Rev; 2002 May; 80(5):74-83, 133. PubMed ID: 12024760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moving upward in a downturn.
    Rigby D
    Harv Bus Rev; 2001 Jun; 79(6):98-105, 147. PubMed ID: 11408981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The competitive advantage of corporate philanthropy.
    Porter ME; Kramer MR
    Harv Bus Rev; 2002 Dec; 80(12):56-68, 133. PubMed ID: 12510538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Competing with giants. Survival strategies for local companies in emerging markets.
    Dawar N; Frost T
    Harv Bus Rev; 1999; 77(2):119-29, 187. PubMed ID: 10387768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.